Search - tctmd.com

Displaying 61 - 80 of 100

Sort: Relevancy | Date

News Daily News

一个登记处未发现CAS病例中近端、远端栓塞防护装置的明显差别

Caitlin E. Cox

April 28, 2015

News Daily News

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Caitlin E. Cox

April 28, 2015

Presentation

Proximal vs Distal Embolic Protection for CAS

Presenter: Jay Giri

April 24, 2015

Presentation

3-Year Outcomes Associated With Embolic Protection in Saphenous Vein Graft Intervention

Presenter: JM Brennan

March 27, 2015

News Daily News

Registry Study: Embolic Protection Does Not Appear to Improve SVG PCI Outcomes

Todd Neale

March 27, 2015

News Daily News

颈动脉支架置入术中首选近端栓塞保护

August 07, 2014

News Daily News

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

August 07, 2014

News Daily News

La Protección Embólica Proximal podría ser la Fórmula Preferida en la Implantación de Stents Carotídeos

August 07, 2014

Presentation

Evaluation of Proximal Protection Devices During CAS as the First Choice for Embolic Protection

Presenter: M. Hornung

July 28, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Presentation TVT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Axel Linke

June 06, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

June 06, 2014

Presentation Fellows 2014

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Manish Parikh

April 13, 2014

News Daily News

Meta-analysis: Cumulative Stroke Higher with CABG vs. PCI; Late Stroke Comparable

Yael L. Maxwell

January 09, 2014

News Conference News ESC 2013

ASSURE: RVX-208 Fails to Stall or Reverse CAD Progression vs. Placebo

September 02, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

Presentation Fellows 2013

Thrombectomy and Embolic Protection Systems

Presenter: Manish Parikh

April 16, 2013

Presentation TCT 2013

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Presenter: Amir Ravandi, Gregor Leibundgut, Patrick Hu, Anand Prasad, Brian Kolski, Bahram Khadivi, Mitul Patel, Ehtisham Mahmud, Yury Miller, Edward Dennis, Joseph Witztum, Sotirios Tsimikas

January 31, 2013

Advertisement

一个登记处未发现CAS病例中近端、远端栓塞防护装置的明显差别

Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS

Proximal vs Distal Embolic Protection for CAS

3-Year Outcomes Associated With Embolic Protection in Saphenous Vein Graft Intervention

Registry Study: Embolic Protection Does Not Appear to Improve SVG PCI Outcomes

颈动脉支架置入术中首选近端栓塞保护

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

La Protección Embólica Proximal podría ser la Fórmula Preferida en la Implantación de Stents Carotídeos

Evaluation of Proximal Protection Devices During CAS as the First Choice for Embolic Protection

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Meta-analysis: Cumulative Stroke Higher with CABG vs. PCI; Late Stroke Comparable

ASSURE: RVX-208 Fails to Stall or Reverse CAD Progression vs. Placebo

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Thrombectomy and Embolic Protection Systems

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content